Posters

Clinical experience with the Clareon® IOL and the AutonoMe® implant system in a series of 391 eyes

Poster Details

First Author: S.Bedar GERMANY

Co Author(s): U. Kellner                    

Abstract Details

Purpose:

The AutonoMe® implantation system pre-loaded with the monofocal, aspherical, hydrophobic Clareon® IOL has recently become available. The aim of this analysis is to present the most comprehensive review of intraoperative and postoperative outcomes to date.

Setting:

Outpatient surgical clinic and referral center

Methods:

The intraoperative features in 391 Clareon® IOL implantations using the AutonoMe® implantation system were evaluated prospectively. In addition, postoperative visual acuity and refractive results of 144 eyes with a follow-up of at least 4 weeks were analyzed. All patients receiving a Clareon® IOL between December 2017 and September 2018 were included, regardless of comorbidities and accompanying ocular surgeries. The SRK®/T formula was used for IOL power calculation.

Results:

There was 1/391 IOL-associated intraoperative complication. However, in this case the posterior haptic was not located correctly and should not have been implanted based on the product information. The mean best corrected visual acuity in all 144 eyes increased from LogMAR 0.32 (SD 0.21) to LogMAR 0.10 (SD 0.21) one month postoperatively. The mean best corrected visual acuity in 90 eyes without ocular comorbidities increased from LogMAR 0.26 (SD 0.18) to LogMAR 0.02 (SD 0.05). At that time, 88% of 144 eyes had a refractive error of ≤0.5 diopters and 98% had a refractive error of ≤1 diopters.

Conclusions:

The present study showed that with adherence to the safety guidelines, the AutonoMe® system allows for safe implantation of the Clareon® IOL. The Clareon® IOL shows good postoperative refraction results using the SRK®/ T formula.

Financial Disclosure:

... gains financially from product or procedure presented